Century Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 BPMC
|
Blueprint Medicines Corporation | $90.23 | $6.47 B | -21.48 | 638 | $249.38 M |
 CCCC
|
C4 Therapeutics, Inc. | $4.20 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $13.45 | $1.29 B | -7.16 | 85 | $0 |
 ERAS
|
Erasca, Inc. | $2.73 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $30.77 | $1.65 B | -11.47 | 108 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GBIO
|
Generation Bio Co. | $1.42 | $216.88 M | -1.28 | 174 | $5.90 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $7.54 | $243.38 M | -1.59 | 133 | $0 |
 KROS
|
Keros Therapeutics, Inc. | $53.98 | $1.76 B | -9.45 | 160 | $151,000 |
 KZR
|
Kezar Life Sciences, Inc. | $7.44 | $49.85 M | -0.49 | 58 | $7.00 M |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.39 | $652.38 M | -6.03 | 28 | $0 |
 NGM
|
NGM Biopharmaceuticals, Inc. | $1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
 NKTX
|
Nkarta, Inc. | $2.50 | $465.09 M | -2.81 | 159 | $0 |
 PASG
|
Passage Bio, Inc. | $0.48 | $73.04 M | -0.77 | 58 | $0 |
 RLAY
|
Relay Therapeutics, Inc. | $4.88 | $1.05 B | -3 | 294 | $25.55 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.89 | $774.50 M | -6.14 | 110 | $8.78 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |